Emerging role of E2F8 in human cancer

Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166745. doi: 10.1016/j.bbadis.2023.166745. Epub 2023 May 8.

Abstract

E2F8 is a multifaceted transcription factor that plays a crucial role in mediating the hallmarks of cancer, including sustaining proliferative signaling, resisting cell death, and activating invasion and metastasis. Aberrant E2F8 expression is associated with poor clinical outcomes in most human cancers. However, E2F8 also exhibits tumor-suppressing activity; thus, the role of E2F8 in cell-fate determination is unclear. In this review, we highlight the recent progress in understanding the role of E2F8 in human cancers, which will contribute to building a conceptual framework and broadening our knowledge pertaining to E2F8. This review provides insight into future challenges and perspectives regarding the translation of biological knowledge into therapeutic strategies for the treatment of cancer.

Keywords: Cancer; E2F8; Oncogene; Tumor suppressor.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / therapy
  • Repressor Proteins / metabolism
  • Signal Transduction*

Substances

  • E2F8 protein, human
  • Repressor Proteins